A
Amanda DeMauro Renaghan
Researcher at University of Virginia Health System
Publications - 8
Citations - 369
Amanda DeMauro Renaghan is an academic researcher from University of Virginia Health System. The author has contributed to research in topics: Acute kidney injury & Medicine. The author has an hindex of 3, co-authored 5 publications receiving 110 citations. Previous affiliations of Amanda DeMauro Renaghan include University of Virginia.
Papers
More filters
Journal ArticleDOI
Clinical features and outcomes of immune checkpoint inhibitor-associated AKI: A multicenter study
Frank B. Cortazar,Zoe A. Kibbelaar,Ilya G. Glezerman,Ala Abudayyeh,Omar Mamlouk,Shveta S. Motwani,Naoka Murakami,Sandra M. Herrmann,Sandhya Manohar,Anushree C. Shirali,Abhijat Kitchlu,Shayan Shirazian,Amer Assal,Anitha Vijayan,Amanda DeMauro Renaghan,David I. Ortiz-Melo,Sunil Rangarajan,A. Bilal Malik,Jonathan J. Hogan,Alex Dinh,Daniel Sanghoon Shin,Kristen A. Marrone,Zain Mithani,Douglas B. Johnson,Afrooz Hosseini,Deekchha Uprety,Shreyak Sharma,Shruti Gupta,Kerry L. Reynolds,Meghan E. Sise,David E. Leaf +30 more
TL;DR: Insight is identified into the risk factors, clinical features, histopathologic findings, and renal and overall outcomes in patients with immune checkpoint inhibitor-associated AKI.
Journal ArticleDOI
Acute kidney injury in patients treated with immune checkpoint inhibitors.
Shruti Gupta,Samuel A.P. Short,Meghan E. Sise,Jason Prosek,Sethu M. Madhavan,María José Soler,Marlies Ostermann,Sandra M. Herrmann,Ala Abudayyeh,Shuchi Anand,Ilya G. Glezerman,Shveta S. Motwani,Naoka Murakami,Rimda Wanchoo,David I. Ortiz-Melo,Arash Rashidi,Ben Sprangers,Ben Sprangers,Vikram Aggarwal,A. Bilal Malik,Sebastian Loew,Christopher A. Carlos,Wei-Ting Chang,Wei-Ting Chang,Pazit Beckerman,Zain Mithani,Chintan V. Shah,Amanda DeMauro Renaghan,Sophie De Seigneux,Luca Campedel,Abhijat Kitchlu,Daniel Sanghoon Shin,Sunil Rangarajan,Priya Deshpande,Gaia M. Coppock,Mark Eijgelsheim,Harish Seethapathy,Meghan Lee,Ian A. Strohbehn,Dwight H. Owen,Marium Husain,Clara García-Carro,Sheila Bermejo,Nuttha Lumlertgul,Nuttha Lumlertgul,Nina Seylanova,Nina Seylanova,Lucy Flanders,Busra Isik,Omar Mamlouk,Jamie S. Lin,Pablo Garcia,Aydin Kaghazchi,Yuriy Khanin,Sheru K Kansal,Els Wauters,Sunandana Chandra,Kai M. Schmidt-Ott,Kai M. Schmidt-Ott,Raymond K. Hsu,Maria C Tio,Suraj Sarvode Mothi,Harkarandeep Singh,Deborah Schrag,Kenar D. Jhaveri,Kerry L. Reynolds,Frank B. Cortazar,David E. Leaf +67 more
TL;DR: In this paper, a multivariable logistic regression model was used to identify predictors of ICPi-AKI and its recovery, and the effect of rechallenge versus no re-challenge on survival was estimated.
Journal ArticleDOI
Acute Kidney Injury and CKD Associated with Hematopoietic Stem Cell Transplantation.
Amanda DeMauro Renaghan,Edgar A. Jaimes,Jolanta Malyszko,Mark A. Perazella,Mark A. Perazella,Ben Sprangers,Mitchell H. Rosner +6 more
TL;DR: Kidney injury directly associated with stem cell transplantation includes a wide range of structural and functional abnormalities, which may be vascular (hypertension, thrombotic microangiopathy), glomerular (albuminuria, nephrotic glomerulopathies), and/or tubulointerstitial.
Journal ArticleDOI
Hypercalcemia: etiology and management
Journal ArticleDOI
Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI
Shruti Gupta,Clara García-Carro,Jason Prosek,Ilya G. Glezerman,Sandra M. Herrmann,Pablo Garcia,Ala Abudayyeh,Nuttha Lumlertgul,A. Bilal Malik,Sebastian Loew,Pazit Beckerman,Amanda DeMauro Renaghan,Christopher A. Carlos,Arash Rashidi,Zain Mithani,Priya Deshpande,Sunil Rangarajan,Sophie de Seigneux,Luca Campedel,Abhijat Kitchlu,Daniel Sanghoon Shin,Gaia M. Coppock,David I. Ortiz-Melo,Ben Sprangers,Vikram Aggarwal,Karolína Benešová,Rimda Wanchoo,Naoka Murakami,Frank B. Cortazar,Kerry L. Reynolds,Meghan E. Sise,María José Soler,David E. Leaf +32 more
TL;DR: A shorter duration of corticosteroids (28 days or less) may be safe for patients with ICPi-AKI, however, the findings may be susceptible to unmeasured confounding and further research from randomized clinical trials is needed.